cefotaxime and Paranasal-Sinus-Diseases

cefotaxime has been researched along with Paranasal-Sinus-Diseases* in 2 studies

Other Studies

2 other study(ies) available for cefotaxime and Paranasal-Sinus-Diseases

ArticleYear
Ethmoidal mucocele causing proptosis in a pediatric patient with cystic fibrosis: A case report.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2022, Volume: 21, Issue:5

    In cystic fibrosis (CF) patients, Ear Nose Throat (ENT) pathology is often undiagnosed despite its high prevalence and its possible life-threatening complications. We present the case of an ethmoidal mucocele leading to ocular manifestations in a 2-year-old girl with cystic fibrosis with no previous serious complications. She progressively developed non-axial proptosis, limitation of the adduction and exotropia of her left eye. Paranasal sinus magnetic resonance image (MRI) showed a left ethmoidal mucocele causing displacement of the ocular globe, compression of the medial rectus and the optic nerve. Eye fundus revealed disc edema and diffuse vascular congestion. Endoscopic sinus surgery was performed to remove the mass. The mucocele was drained and the discharge was sent for microbiology assessment. Escherichia coli (E. coli) was found in the culture and treated with cefotaxime and dexamethasone with complete resolution of non-axial proptosis and disc edema.

    Topics: Cefotaxime; Child; Child, Preschool; Cystic Fibrosis; Dexamethasone; Escherichia coli; Ethmoid Sinus; Exophthalmos; Female; Humans; Mucocele; Paranasal Sinus Diseases

2022
[Ambulatory aerosol therapy in the treatment of chronic pathology of the O.R.L. region].
    Anales otorrinolaringologicos ibero-americanos, 1991, Volume: 18, Issue:3

    This study considers the efficacity of the ambulatory aerosol therapy in chronic cases of the ENT area. A nebulizer, air-jet type, of 4 microns MMAD, was the device employed, and an ample spectre antibiotic (cefotaxime) a mucolytic (N-acetyl-cysteine) plus a corticoid (methyl-prednisolone) the associated drugs. The antibiotic was discarded when otitis were the problem. The results have been favourable in 75 percent of the cases whilst negative in the resting 24 percent of the treated subjects.

    Topics: Acetylcysteine; Aerosols; Ambulatory Care; Cefotaxime; Drug Evaluation; Humans; Methylprednisolone; Otitis Media with Effusion; Paranasal Sinus Diseases; Time Factors

1991